Raymond James & Associates’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,905
| Closed | -$21K | – | 3932 |
|
|
2022
Q3 | $21K | Buy |
4,905
+4,000
| +442% | +$17.1K | ﹤0.01% | 3728 |
|
|
2022
Q2 | $5K | Buy |
905
+255
| +39% | +$1.41K | ﹤0.01% | 3841 |
|
|
2022
Q1 | $8K | Hold |
650
| – | – | ﹤0.01% | 3924 |
|
|
2021
Q4 | $13K | Hold |
650
| – | – | ﹤0.01% | 3945 |
|
|
2021
Q3 | $17K | Hold |
650
| – | – | ﹤0.01% | 3904 |
|
|
2021
Q2 | $14K | Hold |
650
| – | – | ﹤0.01% | 3888 |
|
|
2021
Q1 | $15K | Hold |
650
| – | – | ﹤0.01% | 3812 |
|
|
2020
Q4 | $11K | Buy |
650
+62
| +11% | +$1.05K | ﹤0.01% | 3610 |
|
|
2020
Q3 | $10K | Buy |
+588
| New | +$10K | ﹤0.01% | 3450 |
|
|
2018
Q4 | – | Sell |
-1,426
| Closed | -$195K | – | 3581 |
|
|
2018
Q3 | $195K | Buy |
+1,426
| New | +$195K | ﹤0.01% | 3275 |
|